These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study. Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A Acta Ophthalmol Scand; 2005 Oct; 83(5):600-4. PubMed ID: 16188000 [TBL] [Abstract][Full Text] [Related]
32. Microperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion. Senturk F; Ozdemir H; Karacorlu M; Karacorlu SA; Uysal O Retina; 2010 Sep; 30(8):1254-61. PubMed ID: 20827142 [TBL] [Abstract][Full Text] [Related]
33. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion. Cekiç O; Cakır M; Yazıcı AT; Alagöz N; Bozkurt E; Faruk Yılmaz O Curr Eye Res; 2010 Oct; 35(10):925-9. PubMed ID: 20858114 [TBL] [Abstract][Full Text] [Related]
34. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Sutter FK; Simpson JM; Gillies MC Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370 [TBL] [Abstract][Full Text] [Related]
35. Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion. Bashshur ZF; Ma'luf RN; Allam S; Jurdi FA; Haddad RS; Noureddin BN Arch Ophthalmol; 2004 Aug; 122(8):1137-40. PubMed ID: 15302653 [TBL] [Abstract][Full Text] [Related]
36. Intravitreal cortisone injection for refractory diffuse diabetic macular edema. Er H; Yilmaz H Ophthalmologica; 2005; 219(6):394-400. PubMed ID: 16286802 [TBL] [Abstract][Full Text] [Related]
37. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation. Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M Retina; 2007; 27(9):1201-4. PubMed ID: 18046225 [TBL] [Abstract][Full Text] [Related]
38. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema. Jonas JB; Degenring RF; Kamppeter BA; Kreissig I; Akkoyun I Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306 [TBL] [Abstract][Full Text] [Related]
39. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Jonas JB Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641 [TBL] [Abstract][Full Text] [Related]
40. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion. Cheng KC; Wu WC; Chen KJ Eye (Lond); 2009 Nov; 23(11):2023-33. PubMed ID: 19798117 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]